Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) has signed an agreement to acquire a U.S. Food and Drug Administration Rare Pediatric Disease ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA Mergers and Acquisitions